{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:30:00Z","timestamp":1754145000606,"version":"3.41.2"},"reference-count":28,"publisher":"National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. oncol."],"abstract":"<jats:p>A rare case of hairy cell leukemia with CD10+CD23+ expression and leukocytosis is described. The key point marker for hairy cell leukemia is the presence of the BRAF V600E mutation regardless of the leukocyte count and atypical aberrant CD10+ or CD23+ expression. The presented clinical case report is important for understanding the biology of hairy cell leukemia and emphasizes the role of molecular genetic testing in atypical morpho-phenotyping disease presentation.<\/jats:p>","DOI":"10.15407\/exp-oncology.2025.01.091","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T11:10:20Z","timestamp":1752664220000},"page":"91-95","source":"Crossref","is-referenced-by-count":0,"title":["RARE CASE OF CD10+CD23+ HAIRY CELL LEUKEMIA WITH LEUKOCYTOSIS. CASE REPORT AND LITERATURE REVIEW"],"prefix":"10.15407","volume":"47","author":[{"given":"I.","family":"SKRYPNYK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"MASLOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"LYMANETS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"GUSACHENKO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"YEROSHENKO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"32237","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"13927","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-1748. https:\/\/doi.org\/10.1038\/ s41375-022-01620-2"},{"key":"13928","unstructured":"Troussard X, Ma\u00eetre E, Cornet E. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment."},{"key":"13929","doi-asserted-by":"crossref","unstructured":"Am J Hematol. 2022;97(2):226-236. https:\/\/doi.org\/10.1002\/ajh.26390","DOI":"10.1002\/ajh.26390"},{"key":"13930","doi-asserted-by":"crossref","unstructured":"Robak T, Matutes E, Catovsky D, et al. Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treat- ment and follow-up. Annals Oncol. 2015;26(5):100-107. https:\/\/doi.org\/10.1093\/annonc\/mdv200","DOI":"10.1093\/annonc\/mdv200"},{"key":"13931","unstructured":"Kryachok IA, Titorenko IB. Hairy cell leukemia: a literature review and a clinical case. Clin Oncology. 2019;9(3):140-"},{"key":"13932","unstructured":"https:\/\/doi.org\/10.32471\/clinicaloncology.2663-466X.40.23039 (in Ukrainian)."},{"key":"13933","doi-asserted-by":"crossref","unstructured":"Starchenko II, Filenko BM, Royko NV, et al. Synchronous hairy cell leukemia and hepatocellular carcinoma: a case report. Exp Oncol. 2022;44:259-262. https:\/\/doi.org\/10.32471\/exp-oncology.2312-8852.vol-44-no-3.18302","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-3.18302"},{"key":"13934","unstructured":"Adley BP, Sun X, Shaw JM, Variakojis D. Hairy cell leukemia with marked lymphocytosis. Arch Pathol Lab Med."},{"key":"13935","doi-asserted-by":"crossref","unstructured":";127(2):253-254. https:\/\/doi.org\/10.5858\/2003-127-253-HCLWM","DOI":"10.5858\/2003-127-253-HCLWM"},{"key":"13936","doi-asserted-by":"crossref","unstructured":"Almakadi M, Akram MR, Aldhafeeri D, et al. Hairy cell leukemia with severe leukocytosis. Blood. 2023;142(S1):4426. https:\/\/doi.org\/10.1182\/blood-2023-187034","DOI":"10.1182\/blood-2023-187034"},{"key":"13937","doi-asserted-by":"crossref","unstructured":"Kumar L, Bharti R, Kumar H, Kaushik N. Hairy cell leukaemia \u2014 a rare case presented with leukocytosis. Natl J Lab Med. 2021;10(2):PC01-PC02. https:\/\/doi.org\/10.7860\/NJLM\/2021\/44364:2472","DOI":"10.7860\/NJLM\/2021\/44364.2472"},{"key":"13938","doi-asserted-by":"crossref","unstructured":"Chen YH, Tallman MS, Goolsby C, Peterson L. Immunophenotypic variations in hairy cell leukemia. Am J Clin Pathol. 2006;125:251-259. https:\/\/doi.org\/10.1309\/PMQXVY619Q8Y43AR","DOI":"10.1309\/PMQXVY619Q8Y43AR"},{"key":"13939","unstructured":"Wang L, Tadros AS, Hoh CK, Wang HY. CD10-positive hairy cell leukemia involving multiple deep lymph nodes."},{"key":"13940","doi-asserted-by":"crossref","unstructured":"Clin Lymphoma Myeloma Leuk. 2016;16:e51-e51-3. https:\/\/doi.org\/10.1016\/j.clml.2016.02.041","DOI":"10.1016\/j.clml.2016.02.041"},{"key":"13941","unstructured":"Zhao Hl, Cui Hh, Jin Lf, et al. CD103-CD23+ classical hairy cell leukemia: a case report and review of the literature."},{"key":"13942","doi-asserted-by":"crossref","unstructured":"Medicine. 2021; 100:51(e28262). http:\/\/dx.doi.org\/10.1097\/MD.0000000000028262","DOI":"10.1097\/MD.0000000000028262"},{"key":"13943","doi-asserted-by":"crossref","unstructured":"Tsuber V, Kadamov Y, Brautigam L, et al. Mutations in cancer cause gain of cysteine, histidine, and tryptophan at the expense of a net loss of arginine on the proteome level. Biomolecules. 2017;7(3):49. https:\/\/doi.org\/10.3390\/ biom7030049.","DOI":"10.3390\/biom7030049"},{"key":"13944","doi-asserted-by":"crossref","unstructured":"Garza-Ledezma MA, Tellez-Hinojosa CA, Gonz\u00e1lez-L\u00f3pez EE, D. G\u00f3mez-Almaguer D. Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia. Medicina Universitaria. 2016;18(70):34-41. http:\/\/dx.doi.org\/10.1016\/j. rmu.2015.12.002","DOI":"10.1016\/j.rmu.2015.12.002"},{"key":"13945","doi-asserted-by":"crossref","unstructured":"Schrek R, Donnelly WJ. \u201cHairy\u201d cells in blood in lymphoreticular neoplastic disease and \u201cflagellated\u201d cells of nor- mal lymph nodes. Blood. 1966;27:199-211.","DOI":"10.1182\/blood.V27.2.199.199"},{"key":"13946","doi-asserted-by":"crossref","unstructured":"Parry-Jones N, Joshi A, Forconi F, et al. Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V). Br J Haematol. 2020;191:730-737. https:\/\/doi.org\/10.1111\/bjh.17055","DOI":"10.1111\/bjh.17055"},{"key":"13947","doi-asserted-by":"crossref","unstructured":"Kreitman RJ, Dearden C, Zinzani PL, et al. Moxetumomab pasudotox in heavily pre-treated patients with relapsed\/ refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial. J Hematol Oncol. 2021;14:35. https:\/\/doi.org\/10.1186\/s13045-020-01004-y","DOI":"10.1186\/s13045-020-01004-y"},{"key":"13948","unstructured":"Bohn J-P, Dietrich S. Treatment of classic hairy cell leukemia: targeting minimal residual disease beyond cladribine."},{"key":"13949","doi-asserted-by":"crossref","unstructured":"Cancers. 2022;14(4):956. https:\/\/doi.org\/10.3390\/cancers14040956","DOI":"10.3390\/cancers14040956"},{"key":"13950","doi-asserted-by":"crossref","unstructured":"Robak T, Janus A, Jamroziak K, et al. Vemurafenib and rituximab in patients with hairy cell leukemia previously treated with moxetumomab pasudotox. J Clin Med. 2021;10:2800. https:\/\/doi.org\/10.3390\/jcm10132800","DOI":"10.3390\/jcm10132800"},{"key":"13951","doi-asserted-by":"crossref","unstructured":"Skrypnyk I, Maslova G, Lymanets T, Gusachenko I. L-arginine is an effective medication for prevention of en- dothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia. Exp Oncol. 2017;39:308-311. https:\/\/doi.org\/10.31768\/2312-8852.2017.39(4):308-311","DOI":"10.31768\/2312-8852.2017.39(4):308-311"},{"key":"13952","doi-asserted-by":"crossref","unstructured":"Janowska A, Janus A, Kociszewski K, Robak T. New therapeutic options for hairy cell leukemia. Acta Haematol Pol. 2022;53:39-47. https:\/\/doi.org\/10.5603\/AHP.a2021.0095","DOI":"10.5603\/AHP.a2021.0095"},{"key":"13953","doi-asserted-by":"crossref","unstructured":"Skrypnyk I, Maslova G, Lymanets T, Gusachenko I. How to improve quality of life in patients with acute leuke- mia and comorbid ischemic heart disease treated with anthracyclinebased induction chemotherapy. Exp Oncol. 2019;41:353-356. https:\/\/doi.org\/10.32471\/exp-oncology.2312-8852.vol-41-no-4.13906","DOI":"10.32471\/exp-oncology.2312-8852.vol-41-no-4.13906"},{"key":"13954","doi-asserted-by":"crossref","unstructured":"Anghelina M, Naughton MJ, Zhao Q, et al. Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemia. Leuk Res. 2022;120:106919. https:\/\/doi.org\/10.1016\/j.leukres.2022.106919","DOI":"10.1016\/j.leukres.2022.106919"}],"container-title":["Experimental Oncology"],"original-title":[],"link":[{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/471\/407","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/471\/407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T11:10:36Z","timestamp":1752664236000},"score":1,"resource":{"primary":{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/view\/471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,11]]}},"URL":"https:\/\/doi.org\/10.15407\/exp-oncology.2025.01.091","relation":{},"ISSN":["2312-8852","1812-9269"],"issn-type":[{"type":"electronic","value":"2312-8852"},{"type":"print","value":"1812-9269"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}